MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.
about
The Receptor Tyrosine Kinase AXL in Cancer ProgressionRoles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cellsRole of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations.Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to FibrosisExpression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.MicroRNA‑205 promotes the tumorigenesis of nasopharyngeal carcinoma through targeting tumor protein p53-inducible nuclear protein 1.MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.Gene of the month: Axl.Noncoding RNAs in Growth and Death of Cancer Cells.The inhibitory effects of gga-miR-199-3p, gga-miR-140-3p, and gga-miR-221-5p in Marek's disease tumorigenesis.MicroRNA Exert Macro Effects on Cancer Bone Metastasis.Axl and Mer Receptor Tyrosine Kinases: Distinct and Nonoverlapping Roles in Inflammation and Cancer?MicroRNAs in gynecological cancers: Small molecules with big implications.NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2.Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models.Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.Characterization of the miRNA regulators of the human ovulatory cascade
P2860
Q28068756-DABA5D4F-2632-46A9-807F-6194E91A9316Q28072650-00BECC09-B13C-4356-AC09-9D2E0EA151EFQ33719952-53478968-2222-4836-A158-BA90D342D4FFQ33800254-33C19C68-D22A-45FD-A3A5-C11C03C38771Q35924210-3B08F492-D64A-4108-8E14-2D577DFAF0B2Q36089751-1BBE5BD4-5047-4BB4-92A0-2D2E91136155Q36261465-D23B483B-B0A1-4229-B2EA-D8CCA9318791Q38763966-A7A851DF-2B1A-45DA-BD14-FFE544B2CDC7Q38845436-8DCAB730-93ED-47D2-8B77-5D5BE2450BBEQ38860050-6EF2FAFE-DA33-4CD9-8298-43CB42D91286Q38910342-CF878630-7512-44E1-95B8-144FE02FEE4DQ38936702-02F0E774-BC55-4E32-ADC5-2959AA250A28Q39333266-2A3EA9B3-C5AC-4E12-AA19-083051D07C20Q47135519-C1F602CA-A965-43FF-8A58-3E356C64D97FQ47141265-74178327-6172-48CB-B18D-1F0D5441C3E4Q47247562-664A476A-52B7-4B54-B565-7841FBF0F51FQ49593669-B845BFCD-E2AD-4329-9B4D-4447BDB9C5EEQ57799944-3E5FDEBA-B7E6-48F6-AA01-BED8A37277B2
P2860
MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.
@en
type
label
MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.
@en
prefLabel
MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.
@en
P2093
P2860
P1433
P1476
MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.
@en
P2093
Chunguang Wang
Fengyu Ling
Junxia Liu
Xuejun Shi
P2860
P2888
P304
P356
10.1007/S13277-015-3445-8
P577
2015-04-21T00:00:00Z
P6179
1041955801